Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

Contact Information

Contact UW Carbone Cancer Center for appointment scheduling, patient referrals and more information: 

(608) 262-5223

(800) 622-8922

The University of Wisconsin Carbone Cancer Center, the state's only comprehensive cancer center, is recognized throughout the Midwest and the nation as one of the leading innovators in cancer research, quality patient care and active community involvement.
The UW Carbone Cancer Center is currently one of only two facilities in Wisconsin to offer cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) during surgeries to remove cancerous tumors confined to the peritoneal cavity (abdomen).

What is cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC)?


Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) is a form of chemotherapy used after surgeons perform cytoreductive surgery - removal or reduction of a tumor.


During HIPEC procedures, the surgeons first surgically remove all visible tumors within the abdomen. After all visible tumors have been removed, the heated chemotherapy solution is introduced to the region in surgery and destroys any cancer cells that may still be present.


Candidates for HIPEC Treatment


HIPEC may be used for people suffering from an advanced spread of cancer in the abdomen, with no evidence of cancer outside the abdomen.


Advantages of HIPEC

  • Surgeons can use higher doses of chemotherapy
  • It is a more powerful form of chemotherapy than the traditional method
  • Chemotherapy is applied only to the abdomen, reducing the chance of exposure in other parts of the body and potentially minimizing side effects
  • In comparison to traditional chemotherapy delivery, HIPEC allows for higher doses of chemotherapy treatment to the abdominal cavity. Heating the solution (i.e., hyperthermia) also enhances the power of the chemotherapy, improving absorption by tumors and susceptibility of cancer cells to chemotherapy. Furthermore, because the chemotherapy is kept within the abdomen, it minimizes the rest of the body’s exposure to the treatment, which helps reduce some chemotherapy side effects.